Video Experimental Relacionado
Updated: Jul 19, 2026
04:34
A Novel Non-invasive Method for the Detection of Elevated Intra-compartmental Pressures of the Leg
Published on: May 31, 2019
Stanozolol en el tratamiento de las úlceras en las piernas debido a la criofibrinogenemia
V Falanga1, R S Kirsner, W H Eaglstein
1University of Miami School of Medicine, Department of Dermatology and Cutaneous Surgery, Florida 33136.
Lancet (London, England)
|August 10, 1991
Resumen
El estanozolol trató eficazmente las úlceras dolorosas en las piernas y los trombos dérmicos en pacientes con criofibrinogenemia. El tratamiento condujo a un rápido alivio del dolor, la curación de la úlcera, y la resolución de la criofibrinogenemia y la trombosis.
Área de la Ciencia:
- La medicina vascular es una medicina vascular.
- Dermatología Dermatología dermatología.
- Hematología Hematología.
Sus antecedentes:
- La criofibrinogenemia es una condición rara caracterizada por la precipitación de criofibrinógeno en el plasma.
- Puede estar asociado con úlceras dolorosas en las piernas y trombosis intravascular, lo que lleva a una morbilidad significativa.
- Las opciones actuales de tratamiento para esta afección son limitadas.
Objetivo del estudio:
- Para evaluar la eficacia del estanozolol en el tratamiento de pacientes con criofibrinogenemia.
- Evaluar el impacto del estanozolol en úlceras dolorosas en las piernas y trombosis dérmica.
- Para determinar el efecto del estanozolol en los niveles de criofibrinogenemia.
Principales métodos:
- Se estudió una serie de casos de cinco pacientes consecutivos con criofibrinogenemia.
- Los pacientes fueron tratados con estanozolol, un esteroide androgénico con propiedades fibrinolíticas.
- Se evaluaron los resultados clínicos (dolor, cicatrización de úlceras) y los marcadores de laboratorio (criofibrinogenemia, trombosis).
Principales resultados:
- Los cinco pacientes experimentaron un alivio rápido y significativo del dolor.
- La curación de la úlcera se observó en todos los pacientes tratados.
- La evaluación posterior al tratamiento mostró una resolución de la criofibrinogenemia y la trombosis intravascular dérmica.
Conclusiones:
- El estanozolol es un agente terapéutico prometedor para la criofibrinogenemia asociada con úlceras en las piernas y trombosis.
- El medicamento demuestra eficacia para aliviar el dolor, promover la cicatrización de la úlcera y resolver las anomalías hematológicas subyacentes.
- Se necesita más investigación para confirmar estos hallazgos en estudios más grandes.
Videos de Conceptos Relacionados
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:27Restless Leg Syndrome and Night Terrors
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...